Cite
Prognostic implications of CK19 positivity in patients with early recurrent hepatocellular carcinoma after hepatic resection undergoing transarterial chemoembolization.
MLA
Zhu, Di, et al. “Prognostic Implications of CK19 Positivity in Patients with Early Recurrent Hepatocellular Carcinoma after Hepatic Resection Undergoing Transarterial Chemoembolization.” BMC Gastroenterology, vol. 24, no. 1, Oct. 2024, pp. 1–11. EBSCOhost, https://doi.org/10.1186/s12876-024-03417-2.
APA
Zhu, D., Yang, W., Zhou, H.-F., Shi, H.-B., Liu, S., Shao, Z.-F., & Zhou, W.-Z. (2024). Prognostic implications of CK19 positivity in patients with early recurrent hepatocellular carcinoma after hepatic resection undergoing transarterial chemoembolization. BMC Gastroenterology, 24(1), 1–11. https://doi.org/10.1186/s12876-024-03417-2
Chicago
Zhu, Di, Wei Yang, Hai-Feng Zhou, Hai-Bin Shi, Sheng Liu, Ze-Feng Shao, and Wei-Zhong Zhou. 2024. “Prognostic Implications of CK19 Positivity in Patients with Early Recurrent Hepatocellular Carcinoma after Hepatic Resection Undergoing Transarterial Chemoembolization.” BMC Gastroenterology 24 (1): 1–11. doi:10.1186/s12876-024-03417-2.